Scotland’s National Clinical Director Jason Leitch is becoming a vaccinator and is encouraging more people to enrol to help accelerate the national booster jab programme.
Since 19 November, the equivalent of 300 full-time additional staff (more than 1000 individuals) have joined the national vaccination effort and health boards are actively recruiting to create extra capacity.
Following the most recent advice from the Joint Committee on Vaccination and Immunisation (JCVI) everyone aged 18 and over who is eligible will be offered a slot for the booster jab by the end of January. Currently those aged 40-49 are invited to make an appointment through the online portal or the national helpline, from 12 weeks after their second dose. The national programme is also delivering second doses to 16 and 17 years olds.
Professor Leitch said: “I am pleased to join the fantastic team at NHS Greater Glasgow and Clyde and look forward to helping administer booster jabs to adults and second doses to 16 and 17 years olds as we continue to protect Scotland’s population as quickly as possible.
“To be a small part of this national mission is a real privilege. It also gives me the opportunity to thank the clinical teams and volunteers who have got us this far.
“This has been the biggest immunisation programme in the history of the NHS and the hard work and commitment shown by health boards and vaccination teams across Scotland means we have the highest vaccination rate for people aged 12 and over of all UK nations for first, second and boosters/third doses and the winter vaccination programme has already delivered more than 2 million booster and third doses to the most vulnerable groups, covering 45% of the adult population (aged 18+).
However, we would warmly welcome any former NHS employees and of course, they will receive full training before giving any vaccines. I’ll be helping when I can alongside my main role.
“Even a shift a week will help, so if you’re a dentist, a nurse, an optometrist or a doctor and you can help us then please contact your local health board. Every vaccine dose given is another step out of the pandemic. If you don’t have a clinical background, it’s not a problem, you can still assist the programme in another capacity through the British Red Cross.
“We have accepted the JCVI’s updated recommendations and aim to offer the booster vaccine to everyone aged 18 or older who is eligible by the end of January, and we would love some more vaccinators to join our incredibly national programme to assist us through this particularly busy period.”
Vaccination Programme Director at NHS Greater Glasgow and Clyde Anne Harkness said: “In the last year, our vaccination team at NHSGGC have administered more than 2.1 million jags, working with the public to protect our communities.
“We are continuing to build our pool of vaccinators and we are delighted to welcome Jason to the vaccination team and wish him – and all the new recruits – well.”
People who wish to apply to become a vaccinator can find more information at NHS Scotland
Volunteers who are not currently involved in COVID response, or other critical work, who would be interested in assisting the COVID response generally and the vaccine programme in particular, can find out more by emailing:
An extensive expert review has found failings in the standard of hearing tests carried out for children in NHS Lothian’s Paediatric Audiology service.
The review, conducted independently by the British Academy of Audiology (BAA), identifies significant concerns about hearing tests that were not carried out to the required professional standard, with consequences for children and their families. In some cases, diagnosis of hearing loss or impairment may have been missed or delayed.
Early identification of hearing loss or impairment from birth is important because the earlier it is picked up, the more successfully it can be treated with hearing aids or cochlear implants and the better the outcomes for the child.
Tracey Gillies, Medical Director NHS Lothian said; “We are very sorry and saddened to learn that there are some children whose conditions were not diagnosed correctly, or as early as possible, as a result of testing that was not up to standard.
“Due to these failings, the diagnosis of hearing loss or impairment in six children was missed. Diagnosis of a further six children was significantly delayed with long term consequences for these children. Their long-term development of speech and language will be affected and these children will require specialist support.”
Ms Gillies continued “Delayed diagnosis of hearing loss in a further 48 children is also likely to have resulted in some harm, though the longer-term impact of this will depend on the individual circumstances of each child. Some children may require to be retested.
“We have already written to the most severely-affected families individually to offer support and a face-to-face meeting to discuss their child’s condition. We have also arranged appointments for those children whom the review recommends should be tested again.
“In addition, measures have been put in place to identify young children currently in the system whose cases may require clinical review. If any concerns are found, the families will be contacted immediately.
“We apologise sincerely to all affected children and their families for these failings and for the worry and distress caused. We would encourage families who may have concerns to contact our helpline for information on 0131 465 5457. Lines will be open on Monday to Friday from 9am to 4pm.
“We have been engaging closely with the National Deaf Children’s Society and would like to thank them for the support they are able to provide families via their own helpline, which can be contacted on 0808 800 8880.”
NHS Lothian commissioned the full, external review of the service following criticism in May about the diagnosis and care of a child with hearing difficulties. The review is part of the Health Board’s response to the recommendations made by the Scottish Public Services Ombudsman who investigated that case.
Other actions already taken include the appointment of an additional senior expert to provide support in Paediatric Audiology, a comprehensive training programme for service staff and support from NHS Ayrshire and Arran and NHS Greater Glasgow and Clyde with testing in the interim.
The review consisted of an audit of cases from 2009 -2018, an appraisal of the clinical governance structures in place as well as a week’s residential visit by external experts to observe working practices in the service.
NHS Lothian Chief Executive, Calum Campbell said: “The thoroughness of the review reflects our determination to improve the service and outcomes for the children in our care.
“We note that the report was positive about some aspects of the care of the audiology team who are committed to working hard to improve the quality of testing provided by the service.
“A number of improvements have already been made and a detailed action plan has been developed to implement all the recommendations of the BAA in full.
“We continue to work closely with the BAA and would like to thank them for their diligence and support in conducting the review.
“I apologise to the affected families and give them my assurance that lessons have been learned and that the recommendations from the review are being implemented in full.”
The National Deaf Children’s Society has called for a sweeping review of children’s audiology services in Scotland after almost a decade of failures by NHS Lothian.
At least 887 children are known to have been affected during the nine-year period, 155 significantly, but the actual number could potentially include thousands more and the problems have continued.
The charity has spoken out after a new report, published yesterday, uncovered repeated mistakes by NHS Lothian’s audiology service, with at least 100 deaf children among those affected.
The report reveals cases of deaf children being wrongly deprived of crucial technology, incorrectly discharged or identified years later than they should have been. Some have been left with life-changing consequences as a result.
In response, the charity has today written to the Cabinet Secretary for Health and Social Care, Humza Yousaf MSP. The letter calls for an assurance that such catastrophic errors will never happen again and asks for urgent Government action to improve audiology services across the country.
The failures were revealed in a new audit report, carried out by the British Academy of Audiology to examine NHS Lothian’s children’s audiology caseload of 22,900 from 2009-2018.
It sampled 1,007 cases and found there were concerns about assessment and care in 887 of them (88%). Of those, 155 had “significant concerns”.
The specific findings of the report include:
The average age of children identified as deaf under NHS Lothian was 1,653 days (4.53 years old), compared to 109 days in England. The report says this appeared to have gone “unreported and un-noticed.”
12 children were eligible for cochlear implantation, but this was significantly delayed, to the extent where some missed out on getting them altogether.
There was no evidence that nine of the children were offered a hearing aid, even though it would likely have helped them.
49 children had a delayed identification of hearing loss or the fitting of their hearing aid was delayed.
30 were not offered the right hearing aids.
The remainder of the 155 were wrongly discharged or mismanaged.
As a result, the National Deaf Children’s Society is calling for a review of children’s audiology services across Scotland. It wants to see the Scottish Government introduce national leadership for services, robust data collection and a mandatory program setting out clear standards for care.
Without urgent action, the charity says there’s a real danger that many more deaf children risk not getting the quality of care they need.
Locally, it wants NHS Lothian to commit to following the recommendations made by the report, review its past caseload to avoid repeating the same mistakes and announce a clear plan on how it will catch up and deliver for deaf children and their families.
The charity is also strongly advising all affected families to seek independent specialist legal advice. It is already offering support to families affected and says that anyone who is worried about the report should contact its helpline.
Susan Daniels, Chief Executive at the National Deaf Children’s Society, said:“The horrendous findings in this report represent a real-life nightmare for the families involved.
“They placed their trust in a service that was supposed to help, only to be completely let down. Some will be left with life-changing consequences, while many others across Scotland will now be facing the very real fear that the same thing could happen to them.
“Early identification and the right care are vital in helping deaf children develop language and communication at a crucial age, so this must never be allowed to happen again.
“This means we need urgent action from the Scottish Government, starting with a thorough review of children’s audiology services across the country. Until we have national leadership, better data collection and mandatory standards that services must comply with, thousands more deaf children could be at risk and families won’t be able to rest.
“We’re already in touch with several families affected and we’ve provided them with support and guidance. Anyone else who’s been affected, or feels worried about this issue, can contact our helpline or visit our website at www.ndcs.org.uk.”
Lothian MSP, Miles Briggs said: ““These findings by the British Academy of Audiology are extremely concerning and families in NHS Lothian have been totally failed.
“It is crucial that all 36 recommendations for the paediatric audiology service are implemented as soon as possible.
“The average age for diagnosing hearing loss in NHS Lothian is far too late and measures must be put into place to ensure that children with hearing loss are diagnosed much sooner.
“I have written to the Health Secretary to request a meeting about why it takes four and half years in NHS Lothian for a child to be diagnosed with hearing loss, compared to 109 days in England.”
Given the number of COVID-19 outbreaks that are being linked to Christmas parties, particularly those caused by Omicron, Public Health Scotland (PHS) is URGING PEOPLE TO DEFER SUCH PARTIES AT THIS TIME.
Dr Nick Phin, Director of Public Health Science and Medical Director, PHS explains: “There is much that we still need to learn about Omicron, but early evidence suggests that this new Covid variant is much more transmissible.
“The impact of this transmissibility has been seen in recent weeks, with a number of Omicron outbreaks linked to parties.
“We still need to learn more about the severity of disease caused by Omicron and the effectiveness of vaccines, but there are important things that we can do to help protect ourselves and our families now. To help minimise the further spread of Covid-19, and Omicron in particular, I would strongly urge people to defer their Christmas parties to another time.
“I appreciate that everyone is keen to celebrate this festive season, particularly after the pressures of the last twenty months, but by postponing some plans we can all do our bit to protect ourselves and our loved ones.”
A reminder of the other measures we can all take to continue to keep safe over the festive period:
Please get your vaccine and your booster when your turn comes.
Please test at least twice weekly using LFDs and take a test each time you are socialising with people out with your household.
Reduce the number of people you catch up with. Try to meet outdoors; if indoors, ensure ventilation is good.
Keep up the other public health measures: wash your hands, clean surfaces, maintain distances and of course wear a face covering in public spaces.
It’s understood First Minister Nicola Sturgeon will give a Coronavirus update tomorrow (Friday).
Vaccination teams in Lothian have administered a massive 1.6m doses of the lifesaving COVID-19 vaccine in just 12 months.
As NHS Lothian yesterday marked a year milestone since the first vaccination was administered, figures show that vaccinators have delivered massive numbers of first, second and booster doses of the vaccine, helping in the battle to save countless lives and prevent serious illness.
A total of 712,827 first doses, 657,528 second doses and 266,153 doses of the booster vaccine have been delivered since the programme began, as well as 8,324 doses for patients who are severely immunosuppressed.
Since the annual flu vaccination programme began some weeks ago, vaccination teams have also delivered 278,517 doses of flu vaccine to people who are eligible.
The Cabinet Secretary for Health Humza Yousaf visited the team in Lowland Hall vaccination centre in Royal Highland Centre, Ingliston, yesterday to mark the anniversary of the programme and thank staff for their outstanding efforts.
Laura Hall, centre manager, said: “When I look back on the last year and everything we have achieved, I feel really proud.
“In Lowland Hall so far, we have delivered 330,000 doses of COVID-19 vaccine as part of the Lothian-wide programme. It is a massive achievement.”
NHS Lothian’s vaccination programme, which is the largest of its kind ever to be undertaken, began on 8 December 2020 and over the last 12 months has evolved and grown at rapid pace.
Now, amid fears around the new OMICRON variant and during the run-up to Christmas, the teams are facing one of their busiest stages yet.
Teams have geared up across the board to make more appointments available in all of the centres in Lothian.
Pat Wynne, Nurse Director of Primary and Community Care, NHS Lothian, said: “We have come such a long way in the last year, but we still have more to do.
“We are receiving emerging new information and evidence about the new OMICRON variant, but vaccination remains our best defence.
“Our teams are gearing up across Lothian to make sure we can administer as many doses as possible. We would urge anyone who is eligible for any doses of their vaccine to make an appointment or use one of our drop-in clinics.”
Vaccination programme has been a phenomenal success with almost 120 million doses administered, saving countless lives and reducing pressure on the NHS
A year ago today the UK became the first country in the world to deploy an approved COVID-19 vaccine
Vaccination programme has been a phenomenal success with almost 120 million doses administered across the UK, saving countless lives and reducing pressure on the NHS
Booster programme accelerating, with new vaccine sites opening, support from military and new vaccinator recruitment drive to offer top-up jabs to all adults by end of January
UK approaching 21 million boosters and third doses administered
The UK administered the first COVID-19 vaccine in the world, outside of clinical trials, one year ago today as the Health and Social Care Secretary Sajid Javid urges people to get their booster jab as soon as they are eligible.
On 8 December 2020, 90-year-old Margaret Keenan received a Pfizer-BioNTech vaccine at University Hospital in Coventry, administered by Matron May Parsons.
Thanks to the UK Government’s quick action to secure the most promising vaccine doses in advance, almost 120 million doses have been administered across the UK in a year, saving countless lives and helping stop the NHS from being overwhelmed.
In light of the new Omicron variant and following advice from the Joint Committee on Vaccination and Immunisation (JCVI), the government is expanding the booster programme to all adults over 18 and announced that all eligible people will be offered a top-up jab by the end of January, as well as halving the minimum gap between second doses and boosters.
To speed up the vaccination programme, around 450 military personnel have been drafted in to support deployment, with extra community pharmacy sites, hospital hubs, and pop-up sites opening in convenient locations across the country. Payments to GPs, community pharmacies and primary care staff will help boost capacity and encourage more visits to those who are housebound.
NHS England has also launched a recruitment drive for 10,000 new vaccinators, administration staff, healthcare support workers and volunteers to join the national vaccination mission.
Almost 21 million boosters and third doses have been administered in the UK and, on Saturday, more than 450,000 top-up jabs were administered in a single day. In the last week, the booster programme reached more people than the adult population of Greater Manchester.
Everyone over the age of 40 who had their second dose at least three months ago will soon be able to book an appointment for their booster jab. Younger age groups will be invited by the NHS in order of age in due course. The BT Tower in London will celebrate the anniversary with a message encouraging people to get vaccinated, get boosted and get protected.
Prime Minister Boris Johnson said: “Since the first jab was delivered one year ago today, our phenomenal vaccine rollout has saved hundreds of thousands of lives and given us the best possible protection against Covid-19.
“So many people have been involved in this national vaccination effort, including our brilliant NHS staff, pharmacists, the military, the thousands of volunteers who dedicated themselves to the rollout, the incredible scientists, researchers and their teams who developed these life-saving vaccinations, and crucially every single one of you who has taken up the offer of a jab with such enthusiasm.
“Our fight against the virus is not over yet, but vaccines remain our first and best line of defence against the virus – so the best way to continue to protect yourself and your loved ones is to get behind the vaccine programme and get boosted as soon as you’re eligible.”
Health and Social Care Secretary Sajid Javid said: “I’m incredibly proud of our phenomenal COVID-19 vaccination programme. In one year we have administered almost 120 million doses across the UK, saving countless lives and giving us a powerful weapon to fight this devastating virus.
“The battle is not yet over and we are working around the clock to boost the booster programme to maximise immunity following the emergence of the Omicron variant.
“It is absolutely crucial everybody comes forward for their vaccines and booster jabs as soon as you are eligible so we can strengthen our wall of defence against COVID-19 and enjoy Christmas safely with our families and loved ones this year.”
The first real-world study on the effectiveness of booster vaccines against the dominant Delta variant by the UK Health Security Agency shows top-up jabs boost protection back up to over 90% against symptomatic COVID-19 in adults aged over 50 two weeks after being vaccinated.
As shown in the COV-Boost study, the booster vaccines, Moderna and Pfizer, increase the immune response substantially, which makes it more likely that protection will be maintained against Omicron. The best thing anyone can do given the new variant, is to get a booster.
People who have had their booster vaccine by 11 December will likely have very high protection against COVID-19 by Christmas Day.
Vaccines Minister Maggie Throup said: “Our COVID-19 vaccination programme has been an incredible success. Booster jabs will top-up the immunity people have already developed to ensure we are protected during the winter and ahead of Christmas.
“I encourage everybody to come forward for the first, second, booster and flu vaccines to protect yourself and those around you.”
The COVID-19 vaccination programme is the largest in British history and was established at unprecedented speed. The UK Government’s Vaccines Taskforce secured early access to almost 340 million doses of the most promising vaccine candidates in advance for the entire UK, Crown Dependencies and Overseas Territories, enabling a rapid deployment once approved by the medicines regulator.
New deals have been signed to buy an additional 60 million doses of the Moderna vaccine and 54 million more Pfizer/BioNTech doses for 2022 and 2023. These future supply deals include access to modified vaccines if they are required to combat Omicron and future Variants of Concern.
The UK has one of the highest COVID-19 vaccine uptake rates in the world, with 4 in 5 people aged over-65 in England already receiving their booster jab.
Flu is another winter virus that can be serious. To give people the best protection over winter, those eligible for a free flu vaccine should come forward and book an appointment at either their GP practice or their local pharmacy, or take it up when offered by their employer or other healthcare provider.
Stats from the COVID-19 vaccination programme:
The highest number of new vaccinations reported in one day in the UK was 844,285 on 20 March 2021 – that’s equivalent to vaccinating the entire population of Liverpool in one day.
The highest number of new vaccinations reported in a 7-day period in the UK was 4,215,859 between 15th-21st March 2021 – that’s equivalent to vaccinating the entire population of Birmingham more than four times in a week.
More than 27,000 deaths averted in Scotland
More than ten million vaccination doses have been administered in Scotland since the first jabs against COVID-19 were given exactly one year ago.
The biggest vaccination programme ever undertaken has seen 4,355,063 first doses, 3,962,203 second doses and 1,922,604 boosters and third doses administered from around 1,200 locations.
Staff at 750 GP practices and more than 17,800 vaccinators have worked to protect people from the pandemic.
Recent figures from the World Health Organisation (WHO) estimated that more than 27,000 deaths have been prevented in Scotland as a direct result of the rapid uptake of vaccinations.
Health Secretary Humza Yousaf said: “This has been a year like no other and firstly I would again like to extend my deepest sympathies to all those who have lost loved ones to the virus.
“The national vaccination programme has provided us all with hope for the future. It is an overwhelming success. From the outset, our Health Boards and vaccination teams have worked tirelessly and at extraordinary pace to give everyone the opportunity to be protected against coronavirus over the past twelve months.
“In fact, they have delivered more first, second, booster and third doses per head than any of the other UK nations and we are so grateful for their professionalism and ongoing dedication.
“And of course to those who have taken up the offer of vaccine – thank you. Not only do vaccines reduce the severity of illness and prevent deaths, getting vaccinated may prevent you from unknowingly infecting someone in your household.
“The vaccines we have are extremely safe and highly effective and I urge anyone who is eligible and not yet vaccinated to book an appointment.
“While vaccination is the bedrock of our fight against COVID-19, with the emergence of the Omicron variant it is particularly important that we take other precautions to prevent transmission.
“So test regularly for the virus, particularly before socialising and meeting up with others from outside your household, wear face marks where required and open windows to improve ventilation.”
Data from The Royal College of Emergency Medicine’s Winter Flow Project 2021/22 reveals that in November 2021 6,726 elective care operations were cancelled and in October 2021 6,335 elective care operations were cancelled.
Dr Adrian Boyle, Vice-President of the Royal College of Emergency Medicine, said:“In its first week of reporting, the Royal College’s Winter Flow project 2021/22 has a stark warning for the months ahead.
“Nearly 7,000 elective care operations were cancelled at reporting sites in November alone. This data comes as the National Audit Office, in their latest report, predict that the elective care waiting list could reach 12 million by March 2025.
“Data show 12-hour stays are twice as high as the same time last year; four-hour performance remains incredibly low averaging at 62% in November; long hospital stays have increased 13% since the beginning of October. Urgent and Emergency Care is verging on crisis and it is impacting and derailing elective care, meaning surgery for patients with serious conditions is delayed.
“The situation is unsustainable; we must see a willingness to address these crises and tackle the problems. The core of the issue is poor patient flow throughout the hospital and exit block caused by difficulties in discharging patients. These blockages cause ambulance handover delays, crowding and corridor care.
“Capacity must be expanded to avoid a hard-hitting impact on elective care. While it is crucial that social care is resourced to enable a timely and supported discharge of patients.
“In the long-term, restoring bed capacity to pre-pandemic levels and publishing a long-term workforce plan are vital to ensuring no parts of the system are compromised or derailed; to promoting good flow throughout the system; and keeping patients safe.”
Flu is very infectious and can be serious. Flu can lead to complications that may result in hospitalisation or even death.
The flu vaccine will reduce the risk of your child getting or spreading flu to friends and family who are at greater risk from flu and coronavirus, such as grandparents or people with health conditions.
The flu vaccine provides both individual protection for the child and reduces transmission across all age groups.
Getting the flu vaccine will help prevent the flu virus putting extra strain on our NHS services this winter.
Every year in Scotland, children are hospitalised for the treatment of flu or its complications.
In some cases flu can lead to complications. These can include:
bronchitis
pneumonia
painful middle-ear infection
vomiting
diarrhoea
For children with health conditions getting flu can be even more serious. Health conditions that make children more vulnerable include:
asthma
bronchitis
heart disease
kidney disease
liver disease
neurological disease
diabetes
immunosuppression
asplenia or dysfunction of the spleen
Childhood vaccinations are very important. Please bring your child to their vaccination appointment to protect them and others against flu.
If you think you or your child are showing symptoms of coronavirus call the number on your invitation to rearrange your appointment.
From September 2021 all primary and secondary school pupils in Scotland will be offered the flu vaccine.
How will my child get the vaccine?
The child flu vaccine is normally given at school between September and December.
If your child misses their vaccination in school, please contact your local NHS Board to find out about local arrangements for getting their vaccine at another time.
Home-schooled children are also eligible for the flu vaccine. Your local health board will contact you directly to offer vaccination.
Children aged 6 months to less than 2 years of age with an eligible health condition will also be offered the flu vaccine. Your local health board or GP practice will invite you by letter to get your child’s flu vaccine.
Primary and secondary school-aged children (including those with eligible health conditions) will be offered the vaccine at school.
If a young person has left secondary school, they are not eligible to get a flu vaccine at school. 16 and 17 year olds with an eligible health condition who have left school can phone 0800 030 8013 to receive an appointment for the flu vaccine.
If you don’t know the phone number for your local health board, you can phone 0800 030 8013.
What vaccine is used?
Children aged 2 years and older are given the flu vaccine as a nasal (nose) spray into each nostril. It is quick and painless and is the best available protection against flu.
Your child does not have to sniff or inhale the vaccine and will just feel a tickle in their nose.
The flu vaccine is the safest, most effective protection against flu.
All medicines, including vaccines, are tested for safety and efficacy before they’re allowed to be used.
Once they’re in use, the safety of vaccines continues to be monitored by the Medicines and Healthcare products Regulatory Agency (MHRA).
The nasal spray flu vaccine has been used safely since 2014 and millions of doses of the vaccine have been given to children in the UK
The virus in the vaccine has been weakened so it doesn’t cause flu. It helps your child build up immunity to flu.
Children who don’t get the vaccine are not at risk of catching flu from children who have had the vaccine. The only exception to this would be children who are extremely immunocompromised (have a weakened immune system).
How effective is the vaccine?
The annual vaccine offers protection against the most common types of flu virus that are around each winter. The flu vaccine should start to protect most children about 10 to 14 days after they receive their vaccination.
Over the last few years the flu vaccine has worked very well, providing protection against flu. It has also reduced the chance of spreading flu into the wider community.
There is still a chance that your child could get flu after having the vaccine. If they do get flu after vaccination, it is likely to be milder and not last as long.
Children who can’t have the nasal spray vaccine
An alternative injectable form of the vaccine is available for children who cannot have the nasal spray vaccine.
This includes children who:
have their immune system suppressed because they’re getting treatment for serious conditions, such as cancer, or if they’ve had a transplant
have a serious condition which affects the immune system, such as severe primary immunodeficiency
live with or are in close regular contact with very severely immunocompromised people who require isolation
are taking regular high doses of oral steroids
have had a severe reaction to a previous dose of the vaccine
are undergoing salicylate treatment (for example, taking aspirin)
Children with egg allergies
Children with an egg allergy can safely have the nasal spray vaccine, unless they’ve had a life-threatening reaction to eggs that required intensive care.
An egg-free injectable vaccine which can be used in those from 2 years of age is available. If you’re affected, please speak to your immunisation nurse for advice.
Children with severe asthma
The nasal spray vaccine may not be suitable for some children with severe asthma who regularly need oral steroids for asthma control. If you’re affected, please speak to your health professional for advice.
Children on medications
If your child is at school, please make sure you list all of your child’s medications on the consent form. All consent forms will be checked by a health or immunisation team member before the immunisation session to make sure your child can have the nasal spray.
Pork gelatine
The nasal spray vaccine contains a highly processed form of gelatine (pork gelatine) which is used in many essential medicines.
The gelatine helps keep the vaccine viruses stable so the vaccine provides the best protection against flu.
Many faith groups, including Muslim and Jewish communities, have approved the use of vaccines containing gelatine.
However, it’s your choice whether or not you want your child to get the nasal spray vaccine.
The nasal spray vaccine is a much more effective vaccine than the injected flu vaccine and is the preferred option.
If you do not want your child to get the nasal spray vaccine for religious reasons, you may request the injectable alternative by ticking the box on the consent form (your child won’t automatically be offered the injectable alternative, you’ll need to tick the box every year).
A flock of free-range hens from a commercial premises near Gretna has tested positive for highly pathogenic avian influenza H5N1.
In order to limit the further spread of disease, appropriate restrictions have been imposed on the premises and any identified contact premises, plus the area of the Surveillance Zone, which overlaps into other regions.
The remaining birds at the premises will be humanely culled and a 3km Protection Zone and 10km Surveillance Zone have been declared around the infected premises – taking effect 00:01 on 04 December – to limit the risk of spread of the disease.
Within these zones, a range of different controls are now in place. These include restrictions on the movement of poultry, carcasses, eggs, used poultry litter and manure, and restrictions on bird gatherings.
Producers and bird keepers are reminded to comply with the Order to house birds, which came in to effect on 29 November, or to ensure their birds are kept separate from wild birds. Bird keepers must ensure they follow biosecurity procedures.
The additional housing measures build on the strengthened biosecurity regulations that were brought in across Great Britain as part of the Avian Influenza Prevention Zone (AIPZ) on 3 November 2021 and in and Northern Ireland on 17 November 2021.
Rural Affairs Secretary Mairi Gougeon said: “With the recent disease confirmations in wild and captive birds across the UK, it is not unexpected for avian influenza to be found in birds here in Scotland.
“We ask that the public remain vigilant and report any findings of dead wild birds to Defra’s national telephone helpline. Do not touch or pick up any dead or sick birds that you find.”
Scotland’s Chief Veterinary Officer Sheila Voas said: “We have already made clear that all bird keepers – whether major businesses or small keepers with just a few birds – must ensure that their biosecurity is up to scratch to protect their birds from disease and prevent any contact between their birds and wild birds.
“Keepers who are concerned about the health or welfare of their flock should seek veterinary advice immediately. Your private vet, or your local Animal and Plant Health Agency office, will also be able to provide practical advice on keeping your birds safe from infection.
“Any dead wild swans, geese, ducks or birds of prey, or five or more dead wild birds of other species (including gulls) in the same location at the same time, should be reported to Defra’s national telephone helpline.
“Public health advice is that the risk to human health from the virus is very low and food standards bodies advise that avian influenzas pose a very low food safety risk for UK consumers, and it does not affect the consumption of poultry products including eggs.”
Senior NHSGGC clinicians write to First Minister and Cabinet Secretary over ‘unfounded criticism’ by politicians and in media
Senior clinicians from NHS Greater Glasgow and Clyde have written to First Minister Nicola Sturgeon and Cabinet Secretary for Health and Social Care, Humza Yousaf, to express their disappointment and frustration about the way in which their work and integrity have been portrayed in the Scottish Parliament and the media in recent days.
Here is the full text of that letter:
Dear First Minister and Cabinet Secretary,
Queen Elizabeth University Hospital/Royal Hospital for Children
As NHS Greater Glasgow and Clyde clinicians and clinical leaders, we write to express our immense disappointment and frustration about the way in which our hospitals, our colleagues and the treatment of our patients is being portrayed in the press and the chamber of the Scottish Parliament.
Our highly specialist services care for, treat and support some of the most vulnerable adults, young people and children in the country. Our sole aim is to deliver high quality, person centred care to our patients and focus on what matters most to them; fundamental to this is the strong working relationship between our clinical teams and infection control teams to keep our patients safe.
We have been, and remain, fully committed to being completely open and transparent in all that we do and we are dismayed that the integrity of our staff has been repeatedly called into question. Do we always get everything right when we discuss issues with families? Perhaps not. Do we ever wilfully withhold information from them? Absolutely not.
We have grave concerns that the continued undermining nature of the current negative headlines will result in an erosion of trust between clinical staff and patients and their families. Indeed, we have already seen evidence of the impact this is having on individual patients and carers, with staff reporting that families are very anxious about the safety of their relative while in our care.
We are particularly disappointed that individual patients are being discussed in Parliament without the knowledge of the families concerned, causing untold distress to families already grieving the loss of their loved one.
This unfounded criticism of our clinical teams and staff as well as the safety of our hospitals, is also hugely detrimental to staff morale at a time when so much is being asked of them.
Our staff across NHS Greater Glasgow and Clyde, including the Queen Elizabeth University Hospital campus, provide professional, dedicated care to their patients and as we prepare for a challenging winter, this sustained criticism of our staff is undoubtedly causing them distress and worry.
We are proud of all of our teams, many of which include leading specialists, but we fear that such negativity will have an enormous impact on our ability to recruit and retain such skilled individuals in the future as well as those of wider clinical, nursing and support staff. We will always treat our patients with integrity, dignity, respect and honesty and this should never be in doubt.
We accept that there will always be improvements we can make and learning we can implement, but at the heart of all that we do, is the commitment from every clinician working within NHS Greater Glasgow and Clyde to provide the best quality of care for all of our patients and to be open and honest with them and their loved ones about their diagnosis and treatment.
Anything less would undermine the professional code of practice each of us sign up to at the start of our careers and adhere to throughout.
Yours sincerely
Dr Jennifer Armstrong, Medical Director Dr Margaret McGuire, Nurse Director Dr Scott Davidson, Deputy Medical Director (Acute) Angela O’Neill, Deputy Nurse Director (Acute) Dr Chris Deighan, Deputy Medical Director (Corporate) Dr Kerri Neylon, Deputy Medical Director, Primary Care Mr Wesley Stuart, Chief of Medicine, South Sector Dr Claire Harrow, Chief of Medicine, Clyde Sector Ann-Marie Selby, Interim Associate Chief Nurse Clyde Sector Hon. Professor Colin McKay, Chief of Medicine, North Sector John Carson, Chief Nurse, North Sector Hon. Professor Alistair Leanord, Chief of Medicine, Diagnostics Dr Alan Mathers, Chief of Medicine, Women and Children’s Services Morag Gardner, Chief Nurse, South Sector Mandy Meechan, Interim Chief Nurse, Women and Children’s (designate) Patricia Friel, Interim Chief Nurse, Women and Children Services Dr David Dodds, Chief of Medicine, Regional Services Lorna Loudon, Interim Chief Nurse, Regional Services Dr Martin Culshaw, Associate Medical Director, Mental Health Gail Caldwell, Director of Pharmacy Fiona Smith, AHP Director Evelyn Frame, Chief Midwife Margaret Connelly, Assistant Chief Nurse, Governance and Regulation Lesley Rousselet, Chair, Area Clinical Forum
This monoclonal antibody – the second to be authorised by the Medicines and Healthcare products Regulatory Agency – is for people with mild to moderate COVID-19 who are at high risk of developing severe disease.
Another COVID-19 treatment, Xevudy (sotrovimab), has today been approved by the Medicines and Healthcare products Regulatory Agency (MHRA) after it was found to be safe and effective at reducing the risk of hospitalisation and death in people with mild to moderate COVID-19 infection who are at an increased risk of developing severe disease.
This follows a rigorous review of its safety, quality and effectiveness by the UK regulator and the government’s independent expert scientific advisory body, the Commission on Human Medicines, making it the second monoclonal antibody therapeutic to be approved following Ronapreve.
Developed by GSK and Vir Biotechnology, sotrovimab is a single monoclonal antibody. The drug works by binding to the spike protein on the outside of the COVID-19 virus. This in turn prevents the virus from attaching to and entering human cells, so that it cannot replicate in the body.
In a clinical trial, a single dose of the monoclonal antibody was found to reduce the risk of hospitalisation and death by 79% in high-risk adults with symptomatic COVID-19 infection.
Based on the clinical trial data, sotrovimab is most effective when taken during the early stages of infection and so the MHRA recommends its use as soon as possible and within five days of symptom onset.
Like molnupiravir, it has been authorised for use in people who have mild to moderate COVID-19 infection and at least one risk factor for developing severe illness. Such risk factors include obesity, older age (>60 years), diabetes mellitus, or heart disease.
Unlike molnupiravir, sotrovimab is administered by intravenous infusion over 30 minutes. It is approved for individuals aged 12 and above who weigh more than 40kg.
It is too early to know whether the omicron variant has any impact on sotrovimab’s effectiveness but the MHRA will work with the company to establish this.
Dr June Raine, MHRA Chief Executive said: “I am pleased to say that we now have another safe and effective COVID-19 treatment, Xevudy (sotrovimab), for those at risk of developing severe illness.
“This is yet another therapeutic that has been shown to be effective at protecting those most vulnerable to COVID-19, and signals another significant step forward in our fight against this devastating disease.
“With no compromises on quality, safety and effectiveness, the public can trust that the MHRA have conducted a robust and thorough assessment of all the available data.”
Professor Sir Munir Pirmohamed, Chair of the Commission on Human Medicines, said: “The Commission on Human Medicines and its COVID-19 Therapeutics Expert Working Group has independently reviewed the data and agrees with the MHRA’s regulatory approval of Xevudy (sotrovimab).
“When administered in the early stages of infection, sotrovimab was found to be effective at reducing the risk of hospitalisation and death in high-risk individuals with symptomatic COVID-19. Based on the data reviewed by the Commission and its expert group, it is clear sotrovimab is another safe and effective treatment to help us in our fight against COVID-19.”
Sotrovimab is not intended to be used as a substitute for vaccination against COVID-19.
The government and the NHS will confirm how this COVID-19 treatment will be deployed to patients in due course.
